Cyberonics to Participate in Upcoming Investor Conferences
HOUSTON, Feb. 13, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.
Dan Moore, Cyberonics' President & Chief Executive Officer, will participate in the neuromodulation panel discussion at the Citi 2013 Global Healthcare Conference in New York on Wednesday, February 27, 2013 at 11:05 AM Eastern Time. This panel discussion will not be webcast.
Greg Browne, Cyberonics' Chief Financial Officer, will present at the RBC Capital Markets Global Healthcare Conference in New York on Wednesday, February 27, 2013 at 11:30 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on February 27, 2013.
Mr. Moore will present at the Barclays Global Healthcare Conference in Miami on Tuesday, March 12, 2013 at 1:30 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on March 12, 2013.
About Cyberonics, Inc. and the VNS Therapy® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.
Greg Browne, CFO
100 Cyberonics Blvd., Houston, TX 77058
Main: (281) 228-7262 / Fax: (281) 218-9332
SOURCE Cyberonics, Inc.